Rika Kawakami

Dr. Rika Kawakami

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2025 in European Heart Journal
Verified
Journal Article
Closed access
Luca SabaLuca Saba
Luca Saba
RCRiccardo Cau
Riccardo Cau
RVRocco Vergallo
Rocco Vergallo
MKM Eline Kooi
M Eline Kooi
DSDaniel Staub
Daniel Staub
PLPeter Libby
Peter Libby
Cardiovascular disease remains a prominent cause of disability and premature death worldwide. Within this spectrum, carotid artery atherosclerosis is a complex and multifaceted condition, and a prominent precursor of acute ischaemic stroke and other cardiovascular events. The intricate interplay among inflammation, oxidative stress, endothelial dysfunction, lipid metabolism, and immune responses participates in the development of lesions, leading to luminal stenosis and potential plaque instability. Even non-stenotic plaques can precipitate a sudden cerebrovascular event, regardless of the degree of luminal encroachment. In this context, carotid imaging modalities have proved their efficacy in providing in vivo characterization of plaque features, contributing substantially to patient risk stratification and clinical management. This review emphasizes the importance of identifying high-risk individuals by use of current imaging modalities, biomarkers, and risk stratification tools. Such approaches inform early intervention and the implementation of personalized therapeutic strategies, ultimately enhancing patient outcomes in the realm of cardiovascular disease management.

1 July 2024 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
KKKenji Kawai
Kenji Kawai
RKRika Kawakami
Rika Kawakami
AFAloke V. Finn
Aloke V. Finn
RVRenu Virmani
Renu Virmani

1 January 2022 in Current Atherosclerosis Reports
Verified
Journal Article
Closed access
PDF file
YSYu Sato
Yu Sato
RKRika Kawakami
Rika Kawakami
ASAtsushi Sakamoto
Atsushi Sakamoto
ACAnne Cornelissen
Anne Cornelissen
MMMasayuki Mori
Masayuki Mori
RVRenu Virmani
Renu Virmani

5 July 2024 in Circulation Research
Verified
Journal Article
Closed access
MMMasayuki Mori
Masayuki Mori
ASAtsushi Sakamoto
Atsushi Sakamoto
RKRika Kawakami
Rika Kawakami
LGLiang Guo
Liang Guo
LSLotte Slenders
Lotte Slenders
AFAloke V. Finn
Aloke V. Finn
BACKGROUND: Cell phenotype switching is increasingly being recognized in atherosclerosis. However, our understanding of the exact stimuli for such cellular transformations and their significance for human atherosclerosis is still evolving. Intraplaque hemorrhage is thought to be a major contributor to plaque progression in part by stimulating the influx of CD163 + macrophages. Here, we explored the hypothesis that CD163 + macrophages cause plaque progression through the induction of proapoptotic endothelial-to-mesenchymal transition (EndMT) within the fibrous cap. METHODS: Human coronary artery sections from CVPath’s autopsy registry were selected for pathological analysis. Athero-prone ApoE −/− and ApoE −/− /CD163 −/− mice were used for in vivo studies. Human peripheral blood mononuclear cell–induced macrophages and human aortic endothelial cells were used for in vitro experiments. RESULTS: In 107 lesions with acute coronary plaque rupture, 55% had pathological evidence of intraplaque hemorrhage in nonculprit vessels/lesions. Thinner fibrous cap, greater CD163 + macrophage accumulation, and a larger number of CD31/FSP-1 (fibroblast specific protein-1) double-positive cells and TUNEL (terminal deoxynucleotidyl transferase-dUTP nick end labeling) positive cells in the fibrous cap were observed in nonculprit intraplaque hemorrhage lesions, as well as in culprit rupture sections versus nonculprit fibroatheroma sections. Human aortic endothelial cells cultured with supernatants from hemoglobin/haptoglobin-exposed macrophages showed that increased mesenchymal marker proteins (transgelin and FSP-1) while endothelial markers (VE-cadherin and CD31) were reduced, suggesting EndMT induction. Activation of NF-κB (nuclear factor kappa β) signaling by proinflammatory cytokines released from CD163 + macrophages directly regulated the expression of Snail, a critical transcription factor during EndMT induction. Western blot analysis for cleaved caspase-3 and microarray analysis of human aortic endothelial cells indicated that apoptosis was stimulated during CD163 + macrophage–induced EndMT. Additionally, CD163 deletion in athero-prone mice suggested that CD163 is required for EndMT and plaque progression. Using single-cell RNA sequencing from human carotid endarterectomy lesions, a population of EndMT was detected, which demonstrated significant upregulation of apoptosis-related genes. CONCLUSIONS: CD163 + macrophages provoke EndMT, which may promote plaque progression through fibrous cap thinning.

Verified
Journal Article
Open access
PDF file
ASAtsushi Sakamoto
Atsushi Sakamoto
KSKenichiro Suwa
Kenichiro Suwa
RKRika Kawakami
Rika Kawakami
AFAlexandra V. Finn
Alexandra V. Finn
YMYuichiro Maekawa
Yuichiro Maekawa
AFAloke V. Finn
Aloke V. Finn
Acute coronary syndromes due to atherosclerotic coronary artery disease are a leading cause of morbidity and mortality worldwide. Intra-plaque hemorrhage (IPH), caused by disruption of intra-plaque leaky microvessels, is one of the major contributors of plaque progression, causing a sudden increase in plaque volume and eventually plaque destabilization. IPH and its healing processes are highly complex biological events that involve interactions between multiple types of cells in the plaque, including erythrocyte, macrophages, vascular endothelial cells and vascular smooth muscle cells. Recent investigations have unveiled detailed molecular mechanisms by which IPH leads the development of high-risk “vulnerable” plaque. Current advances in clinical diagnostic imaging modalities, such as magnetic resonance image and intra-coronary optical coherence tomography, increasingly allow us to identify IPH in vivo. To date, retrospective and prospective clinical trials have revealed the significance of IPH as detected by various imaging modalities as a reliable prognostic indicator of high-risk plaque. In this review article, we discuss recent advances in our understanding for the significance of IPH on the development of high-risk plaque from basic to clinical points of view.

1 July 2021 in Atherosclerosis
Verified
Journal Article
Closed access
HSHiroki Shibutani
Hiroki Shibutani
KFKenichi Fujii
Kenichi Fujii
DUDaiju Ueda
Daiju Ueda
RKRika Kawakami
Rika Kawakami
TITakahiro Imanaka
Takahiro Imanaka
ISIchiro Shiojima
Ichiro Shiojima